Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	135	206	196	124	408	341
Market Cap Growth	0.09%	5.07%	57.73%	-69.53%	19.67%	-56.07%
Enterprise Value	125	233	233	154	420	351
Last Close Price	2.75	4.33	4.23	3.04	10.26	8.75
PE Ratio	5.91	9.54	98021.07	-	-	-
Forward PE	8.34	10.57	33.92	-	-	-
PS Ratio	0.55	0.87	0.86	0.49	1.81	1.25
PB Ratio	1.90	3.85	9.07	-50.81	-68.55	19.52
P/TBV Ratio	7.14	-	-	-	-	-
P/FCF Ratio	4.01	7.67	-	6.02	561.16	15.45
P/OCF Ratio	4.00	7.63	-	6.02	527.77	15.24
EV/Sales Ratio	0.51	0.99	1.02	0.61	1.86	1.29
EV/EBITDA Ratio	2.79	5.21	6.04	12.22	-	-
EV/EBIT Ratio	3.77	7.01	8.11	119.32	-	-
EV/FCF Ratio	3.70	8.68	-	7.45	577.31	15.88
Debt / Equity Ratio	1.21	2.09	5.29	-47.69	-20.32	6.88
Debt / EBITDA Ratio	1.74	2.27	2.66	6.78	-	-
Debt / FCF Ratio	2.56	4.15	-	5.65	166.37	5.45
Asset Turnover	1.15	1.04	1.02	1.08	0.94	1.10
Inventory Turnover	17.91	10.80	9.47	12.06	11.89	12.71
Quick Ratio	1.37	1.45	1.59	1.05	1.04	1.55
Current Ratio	1.42	1.57	1.73	1.28	1.28	1.83
Return on Equity (ROE)	42.32%	57.54%	0.02%	-	-1042.30%	-292.05%
Return on Assets (ROA)	9.73%	9.19%	8.00%	0.34%	-7.93%	-9.58%
Return on Capital (ROIC)	13.38%	13.82%	14.36%	0.70%	-15.04%	-14.61%
Earnings Yield	17.22%	10.48%	0.00%	-23.43%	-14.71%	-22.17%
FCF Yield	24.95%	13.04%	-11.64%	16.61%	0.18%	6.47%
Buyback Yield / Dilution	-3.48%	-5.83%	-10.56%	-2.69%	-2.08%	-2.18%
Total Shareholder Return	-3.48%	-5.83%	-10.56%	-2.69%	-2.08%	-2.18%

Source: S&P Capital IQ. Standard template. Financial Sources.